Antiemetics.
This article explores recent knowledge on the physiology and neuropharmacology of the emetic process. It seeks to outline the indications for specific antiemetic drugs and where their actions are targeted. Much of the information for the role of antiemetic drugs has come from experience with antiemetics in patients receiving cytotoxic chemotherapy. The role of the new 5-HT3 receptor antagonists is outlined, with special reference to ondansetron.
Palmerston North Hospital, New Zealand.
S G
SG
Allan
D000932:Antiemetics / Q000493:pharmacokinetics / Q000494:pharmacology; D006801:Humans; D009325:Nausea / Q000188:drug therapy; D018377:Neurotransmitter Agents / Q000493:pharmacokinetics; D012702:Serotonin Antagonists; D014839:Vomiting / Q000503:physiopathology
D000932:Antiemetics; D018377:Neurotransmitter Agents; D012702:Serotonin Antagonists